Shorter radiation + immunotherapy could transform rectal cancer care
NCT ID NCT04928807
Summary
This study compares two treatment approaches given before surgery for locally advanced rectal cancer. One group receives a shorter course of radiation followed by chemotherapy and an immunotherapy drug (camrelizumab). The other group receives the standard longer course of radiation with chemotherapy. The main goal is to see which approach leads to more patients having no detectable cancer cells in their surgical tissue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.